The experimental evidences showed the remarkable up-regulations of serum levels of inflammatory chemokines containing IFN-γ, IL-12, IL-6, IL-13, IL-18 and IL-1β in SLE patients than controls, proving the activation of inflammatory response in SLE. The gene discussed is IL13; the disease is systemic lupus erythematosus.